查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1675351

2025 年至 2033 年按產品類型、人口統計（成年人口、兒童人口）、適應症、最終用戶（診斷/診所、重症監護病房、家庭醫療保健）和地區分類的下一代糖尿病治療和藥物傳輸市場

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic (Adult Population, Child Population ), Indication, End User (Diagnostic/Clinics, Intensive Care Units, Home Healthcare), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球下一代糖尿病治療和藥物輸送市場規模將達到 112 億美元。糖尿病（尤其是第 2 型糖尿病）盛行率的上升、技術的不斷進步以及老年人口的不斷成長是推動市場發展的一些關鍵因素。

下一代糖尿病治療和藥物傳遞程序專注於以微創方式將胰島素引入患者體內，以減少頻繁使用針頭而引起皮膚刺激的風險。這種患者友善方法旨在利用穿戴式感測器、微針和可吸入胰島素等創新技術有效管理疾病，同時降低醫療成本。也採用持續血糖監測系統 (CGMS)、人工胰臟和胰島素貼片等先進療法來改善血糖水平管理，從而最大限度地降低糖尿病相關併發症的風險。此外，該程序還可以輕鬆計算劑量，即時檢查血糖水平，並無痛地將胰島素輸送到體內，進而有助於維持給藥時間。這種治療和藥物傳遞實踐的優點包括改善患者的治療效果、提高治療效率、最大限度地減輕患者的糖尿病管理負擔，從而製定更有針對性的治療計劃。

下一代糖尿病治療和藥物傳輸市場趨勢：

全球市場的主要促進因素是糖尿病，尤其是第 2 型糖尿病在人群中的盛行率不斷上升。這可以歸因於不健康飲食、久坐的生活方式和體力活動減少的增加。與此相符的是，根據個人需求、生活方式和治療目標對個人化和以患者為中心的護理的需求不斷增加，從而導致產品使用率的提高。此外，智慧胰島素筆、閉迴路系統和副作用更少的植入式設備等不斷的技術進步正在為市場提供動力。除此之外，個人對微創和無痛治療方案的日益重視也是推動市場成長的重要因素。醫療保健支出的不斷增加以及對基於價值的醫療保健解決方案的更加關注進一步推動了市場的發展。然而，發展中地區不斷成長的成本限制、缺乏認知以及產品多樣性較低正成為限制市場成長的主要因素。相反，政府在預防保健和早期干預方面實施的優惠措施和報銷政策為市場創造了積極的前景。除此之外，老年人口的不斷成長使得他們更容易患上慢性病，這也對市場產生了積極影響。其他影響市場發展的因素包括快速的城市化、對傳統糖尿病治療相關併發症的認知不斷提高、遠距醫療和數位健康解決方案的採用不斷增加、可支配收入水平不斷上升以及主要參與者開展的廣泛研發 (R&D) 活動。

本報告回答的關鍵問題：

  • 全球下一代糖尿病治療和藥物傳輸市場目前表現如何，未來幾年將如何表現？
  • 全球下一代糖尿病治療和藥物傳輸市場有哪些促進因素、限制因素和機會？
  • 每個促進因素、限制因素和機會對全球下一代糖尿病治療和藥物傳輸市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表了全球最具吸引力的下一代糖尿病治療和藥物傳輸市場？
  • 根據產品類型，市場如何分類？
  • 全球下一代糖尿病治療和藥物傳輸市場中最具吸引力的產品類型是哪一種？
  • 根據人口統計數據，市場如何分類？
  • 全球下一代糖尿病治療和藥物傳輸市場中最具吸引力的人口統計數據是哪一個？
  • 根據指示，市場的分拆情況如何？
  • 全球下一代糖尿病治療和藥物傳輸市場中最具吸引力的適應症是什麼？
  • 根據最終用戶，市場分佈如何？
  • 全球下一代糖尿病治療和藥物傳輸市場中最具吸引力的最終用戶是哪一個？
  • 全球下一代糖尿病治療和藥物傳輸市場的競爭結構是怎麼樣的？
  • 全球下一代糖尿病治療和藥物輸送市場的關鍵參與者/公司是誰？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球下一代糖尿病治療與藥物傳遞市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 吸入式胰島素
  • 口服胰島素
  • 胰島素貼片
  • CGM 系統
  • 人工胰臟

第7章：市場區隔：依人口結構

  • 成年人口（14 歲以上）
  • 兒童人口（14歲）

第 8 章：市場區隔：按適應症

  • 1 型糖尿病
  • 2 型糖尿病

第 9 章：市場區隔：按最終用戶

  • 診斷/診所
  • 重症加護病房（ICU）
  • 家庭醫療保健

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：促進因素、限制因素與機遇

  • 概述
  • 驅動程式
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Dexcom Inc.
    • Eli Lilly and Company
    • Enteris BioPharma Inc. (Swk Holdings Corporation)
    • GlySens Incorporated
    • MannKind Corporation
    • Medtronic plc
    • Sanofi
    • Senseonics
Product Code: SR112025A7519

The global next generation diabetes therapy and drug delivery market size reached USD 11.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 37.0 Billion by 2033, exhibiting a growth rate (CAGR) of 13.52% during 2025-2033. The rising prevalence of diabetes, particularly type-2 diabetes, continual technological advancements, and the growing geriatric population represent some of the key factors driving the market.

Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient's body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.

Next Generation Diabetes Therapy and Drug Delivery Market Trends:

The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions. However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.

Key Market Segmentation:

Product Type Insights:

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

Demographic Insights:

  • Adult Population (>14 Years)
  • Child Population (14 Years)

Indication Insights:

  • Type 1 diabetes
  • Type 2 diabetes

End User Insights:

  • Diagnostic/Clinics
  • Intensive Care Units (ICUs)
  • Home Healthcare

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
  • What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
  • What are the key regional markets?
  • Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the demographic?
  • Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market?
  • What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
  • Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next Generation Diabetes Therapy and Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Inhalable Insulin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Oral Insulin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Insulin Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CGM Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Artificial Pancreas
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Demographic

  • 7.1 Adult Population (>14 Years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Child Population (14 Years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Type 1 Diabetes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type 2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Diagnostic/Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Intensive Care Units (ICUs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Healthcare
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Dexcom Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Eli Lilly and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlySens Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 MannKind Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Senseonics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2024
  • Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
  • Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million USD), 2025-2033
  • Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
  • Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players